ibrutinib
chemical compound
Facts
18 properties- Instance of
- type of chemical entity
- Subclass of
- 1-[3-[4-amino-3-(4-phenoxyphenyl)-1-pyrazolo[3,4-d]pyrimidinyl]-1-piperidinyl]-2-propen-1-one[7]
- Has use
- medication[8]
- Active ingredient in
- Imbruvica
- Canonical SMILES
- C=CC(=O)N1CCCC(C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=NC=N3)N[5]
- Chemical formula
- C₂₅H₂₄N₆O₂[6]
- Has active ingredient
- Ibrutinib
- Has parts
- carbon
- Isomeric SMILES
- C=CC(=O)N1CCC[C@H](C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=NC=N3)N
- LiverTox likelihood score
- LiverTox toxicity likelihood category D
- Mass
- 440.196 Da
- Medical condition treated
- leukemia, central nervous system lymphoma, mantle cell lymphoma, Waldenström macroglobulinemia, chronic lymphocytic leukemia, lymphoblastic leukemia, graft-versus-host disease, non-Hodgkin lymphoma, lymphoma, B-cell lymphoma, diffuse large B-cell lymphoma
- Physically interacts with
- BLK proto-oncogene, Src family tyrosine kinase, BMX non-receptor tyrosine kinase, Bruton's tyrosine kinase[2][3][4]
- Pregnancy category
- US pregnancy category D
- Significant drug interaction
- aspirin, clopidogrel, eptifibatide, tirofiban, abciximab, prasugrel, ticagrelor, rac-warfarin, acenocoumarol, rivaroxaban, apixaban, imatinib, crizotinib, idelalisib
- Subject has role
- protein kinase inhibitors
- World Health Organisation international non-proprietary name
- ibrutinib
🏷️ Also known as
en PCI32765
en 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one
en ibrutinib
en Ibrutinib
en Imbruvica®
en PCI 32765
en PCI-32765
ar إبروتينيب
fa ایبروتینیب
fi ibrutinibi
he איברוטיניב
ja イブルチニブ
ru ибрутиниб
tr İbrutinib
uk ібрутиніб
zh 依魯替尼
zh 依鲁替尼
🔖 Identifiers · 35
- OpenAlex ID
- C2779878957
- ATC code
- L01XE27
- CAS Registry Number
- 936563-96-1
- ChEBI ID
- 76612
- ChEMBL ID
- CHEMBL1873475
- ChemSpider ID
- 26637187
- DSSTOX compound identifier
- DTXCID601323465
- DSSTox substance ID
- DTXSID60893450
- DrugBank ID
- DB09053
- DrugCentral ID
- 4810
- EC number
- 805-642-2
- ECHA Substance Infocard ID
- 100.232.543
Show all 35 identifiers +23
- Freebase ID
- /m/0hr5hzf
- Guide to Pharmacology Ligand ID
- 6912
- HSDB ID
- 8260
- InChIKey
- XYFPWWZEPKGCCK-GOSISDBHSA-N
- KEGG ID
- D10223
- LiverTox ID
- Ibrutinib
- MedlinePlus drug identifier
- a614007
- Microsoft Academic ID (discontinued)
- 2779878957
- NDF-RT ID
- N0000189502
- National Drug Code
- 65129-1471, 11014-0417, 63850-8089, 76397-052, 55111-982, 65129-1460, 11014-0163, 71796-053, 83137-0004, 11014-0397, 15308-2402, 11014-0326
+10 more
11014-0327, 0074-2628, 11014-0328, 58175-0602, 65129-1377, 0074-0070, 68554-0109, 82920-031, 11014-0329, 40006-040 - PDB ligand ID
- 1E8
- Probes And Drugs ID
- PD003357
- PubChem CID
- 24821094
- Reaxys registry number
- 13102252
- RxNorm CUI
- 1442981
- SureChEMBL ID
- 201859
- UK Parliament thesaurus ID
- 446352
- UMLS CUI
- C3501358
- UNII
- 1X70OSD4VX
- UniChem compound ID
- 1110206
- WikiProjectMed ID
- Ibrutinib
🔗 Connections
Significant drug interaction 14
aspirin,
rac-warfarin,
clopidogrel,
imatinib,
rivaroxaban,
apixaban,
acenocoumarol,
prasugrel
+6 more
← Significant drug interaction 14
aspirin,
rac-warfarin,
clopidogrel,
imatinib,
rivaroxaban,
apixaban,
acenocoumarol,
prasugrel
+6 more
Medical condition treated 9
← Drug or therapy used for treatment 9
Has part(s) 1
Has use 1
Physically interacts with 1
Subject has role 1
← Physically interacts with 1
Press Enter · cited answer in seconds
0 sources
Summary
ibrutinib is a type of chemical entity[1].